Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are carriers for MEFV mutations "healthy"?

M Kalyoncu1, B C Acar, N Cakar

  • 1Hacettepe University Faculty of Medicine, Department of Pediatrics, Pediatric Nephrology and Rheumatology Unit, Ankara, Turkey.

Clinical and Experimental Rheumatology
|October 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Juvenile and adult-onset scleroderma: Different clinical phenotypes.

Seminars in arthritis and rheumatism·2023
Same author

Interleukin -17 and oxidative stress in children with immunoglobulin A vasculitis.

Scandinavian journal of rheumatology·2021
Same author

Renal Autotransplantation in a Patient with Bilateral Renal Artery Stenosis Secondary to Takayasu Arteritis.

International journal of organ transplantation medicine·2020
Same author

Vitamin D binding protein genotype frequency in familial Mediterranean fever patients.

Scandinavian journal of rheumatology·2020
Same author

In the presence of hypokalemia and hypomagnesemia; remember Gitelman syndrome.

Hippokratia·2020
Same author

Hepatitis A virus vaccination in childhood-onset systemic lupus erythematosus.

Lupus·2018
Same journal

The expanded cardiovascular risk prediction score as a cardiovascular mortality predictor in rheumatoid arthritis.

Clinical and experimental rheumatology·2026
Same journal

Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison.

Clinical and experimental rheumatology·2026
Same journal

Clinical features and gastrointestinal bleeding risk factors in IgA vasculitis patients: a retrospective study in a large volume centre.

Clinical and experimental rheumatology·2026
Same journal

Reply to the comment on: The microbiota in axial spondyloarthritis: what have we learned from Mendelian randomisation studies?

Clinical and experimental rheumatology·2026
Same journal

Comprehensive evaluation of bone structural and microarchitectural changes in rheumatoid arthritis treated with baricitinib using HR-pQCT, imaging, and biomarker analyses.

Clinical and experimental rheumatology·2026
Same journal

Tracking interstitial lung disease in systemic sclerosis: integrating lung magnetic resonance imaging into a clinically oriented multimodal follow-up strategy.

Clinical and experimental rheumatology·2026
See all related articles

MEFV mutation carriers show increased inflammatory symptoms like fever and joint pain, but lower allergy rates. This suggests carrier status alters health, potentially indicating heightened inflammation.

Area of Science:

  • Genetics and Molecular Biology
  • Immunology
  • Rheumatology

Background:

  • Familial Mediterranean Fever (FMF) is an autoinflammatory disease caused by mutations in the MEFV gene.
  • MEFV mutation carriers, who do not have FMF, are hypothesized to have altered inflammatory profiles.
  • Understanding the phenotype of MEFV carriers is crucial for genetic counseling and disease management.

Purpose of the Study:

  • To compare the frequency of inflammatory symptoms and diseases in asymptomatic carriers of MEFV mutations versus a control population.
  • To investigate whether MEFV carrier status is associated with specific health alterations.

Main Methods:

  • A cross-sectional study surveying parents of children with FMF (carriers) and parents of healthy children (controls).
  • A questionnaire collected data on various inflammatory symptoms, diseases, and medical history, including febrile episodes, arthralgia, and allergies.

Related Experiment Videos

  • Data analyzed from 676 parents of FMF patients and 774 control parents.

    • Main Results:

    • MEFV mutation carriers reported significantly higher frequencies of febrile episodes (>4/year), arthralgia, and prior diagnoses of acute rheumatic fever and rheumatoid arthritis.
    • Carriers also showed a significantly lower frequency of allergies compared to controls.
    • No significant differences were observed in the rates of urinary tract infections or tonsillectomies.

    Conclusions:

    • The findings suggest that carrying MEFV mutations may confer a predisposition to heightened inflammation, as indicated by increased inflammatory symptoms.
    • MEFV carrier status appears to uniquely influence an individual's health state, potentially leading to subclinical inflammatory changes.
    • Further research is warranted to elucidate the precise mechanisms and clinical implications of MEFV carrier status.